down arrow

Jagsonpal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
214.00
12.1 (5.99%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 56.00% vs -15.34% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 18.92% vs 825.00% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Jagsonpal Pharma With
Markets Mojo
Figures in Rs cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
136.13
4,933.00
-4,796.87
-97.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
136.13
4,933.00
-4,796.87
-97.24%
Raw Material Cost
9.59
386.36
-376.77
-97.52%
Purchase of Finished goods
42.07
988.27
-946.20
-95.74%
(Increase) / Decrease In Stocks
-2.99
15.23
-18.22
-119.63%
Employee Cost
31.41
1,047.96
-1,016.55
-97.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
29.53
1,170.95
-1,141.42
-97.48%
Total Expenditure (Excl Depreciation)
109.61
3,608.77
-3,499.16
-96.96%
Operating Profit (PBDIT) excl Other Income
26.52
1,324.23
-1,297.71
-98.00%
Other Income
3.10
200.59
-197.49
-98.45%
Operating Profit (PBDIT)
29.62
1,524.82
-1,495.20
-98.06%
Interest
0.44
8.18
-7.74
-94.62%
Exceptional Items
-3.29
61.23
-64.52
-105.37%
Gross Profit (PBDT)
25.89
1,516.64
-1,490.75
-98.29%
Depreciation
3.41
168.82
-165.41
-97.98%
Profit Before Tax
22.48
1,347.82
-1,325.34
-98.33%
Tax
5.69
261.13
-255.44
-97.82%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.79
1,086.69
-1,069.90
-98.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
16.79
1,147.92
-1,131.13
-98.54%
Equity Capital
13.24
40.06
-26.82
-66.95%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.54
28.66
-26.12
-91.14%
Diluted Earnings per share
2.49
28.61
-26.12
-91.30%
Operating Profit Margin (Excl OI)
19.48%
26.84%
0.00
-7.36%
Gross Profit Margin
19.02%
30.74%
0.00
-11.72%
PAT Margin
12.33%
22.03%
0.00
-9.70%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 136.13 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023

Half Yearly - Standalone Net Profit
Standalone Net Profit 16.79 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.52 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 56.00% vs -15.34% in Sep 2023

Half Yearly - Interest
Interest 0.44 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 18.92% vs 825.00% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.48%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023